Miconazole nitrate in the topical treatment of dermatomycoses. A clinical evaluation.
D000284:Administration, Oral; D000293:Adolescent; D000328:Adult; D000368:Aged; D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use*; D001593:Benzyl Compounds / Q000009:adverse effects / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003881:Dermatomycoses / Q000188:drug therapy*; D004987:Ethers / Q000009:adverse effects / Q000627:therapeutic use; D005148:Facial Dermatoses / Q000139:chemically induced; D005260:Female; D006118:Griseofulvin / Q000008:administration & dosage; D006801:Humans; D007093:Imidazoles / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D007223:Infant; D008297:Male; D008875:Middle Aged; D009566:Nitrates / Q000009:adverse effects / Q000627:therapeutic use; D009824:Ointments; D011208:Powders; D014005:Tinea / Q000188:drug therapy
D000935:Antifungal Agents; D001593:Benzyl Compounds; D004987:Ethers; D007093:Imidazoles; D009566:Nitrates; D009824:Ointments; D011208:Powders; D006118:Griseofulvin